RE:RE:RE:AMCO Drug PricesCdnNewby wrote: There's an article in The New York Times today on just this topic.
" Race to Poach London's Businesses" by Scott, Ewing and Bray
The vote results were seen as a sense of opportunity by other countries in the EU.
I think Britain will be making concessions to keep companies within their borders.
I would also think that the government/National health service will be even more focused on saving tax dollars for citizens now .... so AMCO/Conordia may not be able to strip brands and relaunch as generics with price increases under the radar as they have done in the past..... Thank you Cookie monster for drawing my attention to Billy Kenber's twitter account as I try to get up to spead on affects of Brexit. I saw a post by Shaun Lintern on July 11 on billey Kenber's twitter .... The letter posted parliament.uk/documents//comm..... from the Health Secretary was quite clear that they aare taking the loophole of rebranding very seriously.... Questionable really as how much Concordia is to blame and how much was done by AMCo before Concordia aquired from Cinven...who looks like they acquired AMdipharm Mercury from those two brothers from India. Is it a "Valeant of the UK"? ... awful really what those two guys did and almost reminds me of what Martin Shkreli did in the U.S..... However, no question government will be more focused on saving money now, especially in the drugs administered out of the hospitals.